Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2016 /
Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry

7th - 11th Oct 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.10.16
Views: 1576

Dr Simon Chowdhury - Guy's Hospital, London, UK

Dr Chowdhury talks to ecancertv at ESMO 2016 about the Cancer Registry, that monitors the treatments and outcomes of over 3,000 patients across Europe with metastatic castration-resistant prostate cancer (mCRPC).

Dr Chowdhury also spoke with ecancer about fatigue among mCRPC patients treated with enzalutamide here.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation